2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Diabetes Mellitus, Type 2
1
Cushing Syndrome
1
ACTH Syndrome, Ectopic
1
Interventions
relacorilant
5
Pioglitazone
4
Metformin
4
Sitagliptin Phosphate
3
Resistance Training
3
Dipeptidyl-Peptidase IV Inhibitors
3
saxagliptin
2
Vildagliptin
2
Sulfonylurea Compounds
2
Rosiglitazone
2
Nutritional Status
2
Blood Specimen Collection
2
voglibose
1
somapacitan
1
semaglutide
1
repaglinide
1
pembrolizumab
1
miglitol
1
metahexamide
1
meglitinide
1
mazdutide
1
glymidine
1
glisoxepide
1
gliquidone
1
glimepiride
1
glibornuride
1
empagliflozin
1
dapagliflozin
1
alogliptin
1
Urine Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Type 2
×
ASP3662
×
Clear all
NCT07296484
2026-05-12
CAPTAIN-T2D
Sparrow Pharmaceuticals
Phase 2
Recruiting
1,500 enrolled